Raymond James & Associates Lowers Holdings in Repligen Co. (

Raymond James & Associates lowered its holdings in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,911 shares of the biotechnology company’s stock after selling 529 shares during the quarter. Raymond […]

Related Keywords

Arizona , United States , Alaska , Canada , America , Martind Madaus , Stifel Nicolaus , Craig Hallum , Securities Exchange Commission , Exchange Commission , Deutsche Bank Aktiengesellschaft , Advisors Inc , Commerce Bank , Repligen Corp , Alaska Department Of Revenue , Royal Bank , Raymond James Associates , Keycorp , Repligen Co , Nasdaq , Raymond James , Get Rating , Alaska Department , State Retirement System , Director Martin , Asia Pacific Region , Visit Holdingschannel , Repligen Daily , Repligen , Nasdaq Rgen , Rgen , Medical , 75991610 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,